MALINDA BABCOCK: Open Payments
NPI 1124303730 · MORTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 36 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $599 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $210 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $139 |
| Novo Nordisk Inc | 6 | $121 |
| Lilly USA, LLC | 5 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Abbott Laboratories | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: QULIPTA, JARDIANCE, MOUNJARO, Kerendia, Wegovy, Ozempic, FREESTYLE LIBRE 3, UBRELVY.
Industry payments across IL — which companies pay providers there.
